MLANA and neoplasm: In order to determine whether such an NP-based Melan A vaccine can successfully induce a tumor Ag-specific human CD8+ T cell response “in vivo,” we have utilized a humanized mouse model, which mimics the human immune system and includes functional human CD8+ T cells (28), iNKT cells (27), and human CD141+ DCs (29).